bioequivalence testing
FDA Launches Pilot Program to Prioritize U.S. Generic Drug Manufacturing and Testing
FDA; pilot program; generic drugs; ANDA prioritization; domestic manufacturing; bioequivalence testing; U.S. pharmaceutical supply chain; drug approval; supply chain resilience